Article

Systemic therapy eases dry eye symptoms

Lexington, SC-BioTears Oral Gel Caps (Bio-syntrx) is a systemic treatment for dry eye, specifically designed to address the root inflammatory causes and resulting symptoms of dry eye syndrome. It is the newest product from the researchers who developed HydroEye.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) CCOI Myopia Workshop: Michael X. Repka, MD, MBA, on building consensus and future directions
(Image credit: Ophthalmology Times) Introducing iOpeners: Unpacking high-yield ophthalmology tips and clinical pearls, with Nicole Bajic, MD
Related Content
FDA issues complete response letter to Outlook Therapeutics for resubmitted BLA for ONS-5010
August 29th 2025

FDA issues complete response letter to Outlook Therapeutics for resubmitted BLA for ONS-5010

3 Things You Should Know About the GA Pipeline
August 29th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

(Image credit: AdobeStock/racesy) Q&A: Inside the CCOI Myopia Workshop with Assoc Prof Daniel Ting
August 29th 2025

Q&A: Inside the CCOI Myopia Workshop with Assoc Prof Daniel Ting

Patient-Centered Treatment Strategies in the Management of nAMD and DME
August 29th 2025

Patient-Centered Treatment Strategies in the Management of nAMD and DME

Surgical innovation in dry eye disease: Salivary gland transplant
August 29th 2025

Surgical innovation in dry eye disease: Salivary gland transplant

identifeye HEALTH launches retinal screening platform
August 29th 2025

identifeye HEALTH launches retinal screening platform

© 2025 MJH Life Sciences

All rights reserved.